Lukas Neuhann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Lukas Neuhann has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Aylin Garip-Kuebler
Department of Ophthalmology, LMU University Hospital, LMU Munich, Munich, Germany; and
2 shared publicationsDiana Vogel
MVZ Prof. Neuhann, Munich, Germany
2 shared publications- Adnan Kilani
Department of Ophthalmology, Ulm University Hospital, Ulm, Germany
1 shared publication - Andreas Laner
Medizinisch Genetisches Zentrum (MGZ) München, 80335 Munich, Germany
1 shared publication - Barbara Sophie Brunner
Department of Ophthalmology, University Hospital, LMU Munich, Mathildenstrasse 8, 80336 Munich, Germany
1 shared publication Carina Neuhann
MVZ Prof. Neuhann, Munich, Germany
1 shared publication
Latest Publications
- Open Access
Impact of Iris Color and Laterality on Lenticule Extraction Time in Keratorefractive Lenticule Extraction (KLEx)
Purpose: This study aims to evaluate the effects of iris color and laterality on keratorefractive lenticule extraction (KLEx) surgery time. Setting: A retrospective analysis was conducted on 656 eyes of 328 patients undergoing small incision lenticule extraction (SMILE). Mean patient age was 32 ± 7 years. Methods: Preoperative parameters, including manifest refraction spherical equivalent (MRSE), refractive cylinder, and corrected distance visual acuity (CDVA), were measured. Iris color was classified as “light” (n = 390) or “dark” (n = 266) by a senior ophthalmologist as the grader. Surgical time was determined from video recordings, defined as the time between opening of the KLEx incision and extraction of the lenticule. The surgery was performed by a single highly experienced, right-handed refractive surgeon. Results: Eyes with light irides showed significantly shorter lenticule extraction times than those with dark irides (75 ± 22 s vs. 90 ± 31 s, p < 0.0001). No statistically significant differences were found between eyes with light and dark irides in terms of postoperative MRSE, refractive cylinder, uncorrected distance visual acuity (UDVA), CDVA, safety and efficacy index, respectively (p > 0.05 for all). Surgical time was significantly shorter in right eyes compared to left eyes (74 ± 25 s vs. 89 ± 27 s, p < 0.0001). When analyzing laterality and iris color, surgery was shortest in right eyes with light irides (68 ± 19 s) and longest in left eyes with dark irides (97 ± 31 s; p < 0.0001). Conclusions: SMILE surgery took significantly less time in patients with light irides and in the right eyes compared to dark irides and the left eyes. These findings suggest that patients’ iris color and laterality in relation to surgeon handedness may influence the ease of surgical lenticule extraction to a comparable extent.
Open AccessImpact of Iris Color and Laterality on Lenticule Extraction Time in Keratorefractive Lenticule Extraction (KLEx)
Purpose: This study aims to evaluate the effects of iris color and laterality on keratorefractive lenticule extraction (KLEx) surgery time. Setting: A retrospective analysis was conducted on 656 eyes of 328 patients undergoing small incision lenticule extraction (SMILE). Mean patient age was 32 ± 7 years. Methods: Preoperative parameters, including manifest refraction spherical equivalent (MRSE), refractive cylinder, and corrected distance visual acuity (CDVA), were measured. Iris color was classified as “light” (n = 390) or “dark” (n = 266) by a senior ophthalmologist as the grader. Surgical time was determined from video recordings, defined as the time between opening of the KLEx incision and extraction of the lenticule. The surgery was performed by a single highly experienced, right-handed refractive surgeon. Results: Eyes with light irides showed significantly shorter lenticule extraction times than those with dark irides (75 ± 22 s vs. 90 ± 31 s, p < 0.0001). No statistically significant differences were found between eyes with light and dark irides in terms of postoperative MRSE, refractive cylinder, uncorrected distance visual acuity (UDVA), CDVA, safety and efficacy index, respectively (p > 0.05 for all). Surgical time was significantly shorter in right eyes compared to left eyes (74 ± 25 s vs. 89 ± 27 s, p < 0.0001). When analyzing laterality and iris color, surgery was shortest in right eyes with light irides (68 ± 19 s) and longest in left eyes with dark irides (97 ± 31 s; p < 0.0001). Conclusions: SMILE surgery took significantly less time in patients with light irides and in the right eyes compared to dark irides and the left eyes. These findings suggest that patients’ iris color and laterality in relation to surgeon handedness may influence the ease of surgical lenticule extraction to a comparable extent.
- 11 June 2026
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
Handlungspfad Neurotrophe Keratopathie
Dieser Handlungspfad soll das grundlegende zeitgenössische Verständnis des Krankheitsbildes „Neurotrophe Keratopathie“ zusammenfassen und die daraus resultierenden Prinzipien für das diagnostische und therapeutische Management verständlich ableiten. Article published online: 11 June 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 11 June 2026
- Published by Georg Thieme Verlag KG in Klinische Monatsblätter für Augenheilkunde
Handlungspfad Neurotrophe Keratopathie
Dieser Handlungspfad soll das grundlegende zeitgenössische Verständnis des Krankheitsbildes „Neurotrophe Keratopathie“ zusammenfassen und die daraus resultierenden Prinzipien für das diagnostische und therapeutische Management verständlich ableiten. Article published online: 11 June 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
- 10 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (20) , 9854
Next-Generation Sequencing in Congenital Eye Malformations: Identification of Genetic Causes and Comparison of Different Panel-Based Diagnostic Strategies
Congenital eye malformations like microphthalmia–anophthalmia–coloboma (MAC), anterior segment dysgenesis (ASD), primary congenital glaucoma (PCG) and congenital cataracts (CC) are significant causes of childhood visual impairment. Phenotypic heterogeneity often complicates diagnosis. The goal of this study was to optimize the diagnostic strategy for next-generation sequencing (NGS)-based procedures, thereby aiming to identify genetic causes of congenital eye malformations. Forty patients with congenital eye malformations were included. A primary diagnostic testing (PD) of a limited number of genes was followed by multigene panel (MGP) testing, including 186 eye-related genes, and exome sequencing. Causative variants were identified in 17 patients (43%) and clinically relevant variants of uncertain significance (VUS) in 6 patients (15%). PD had a diagnostic yield (DY) of 15%, MGP of 29% and exome sequencing of 4%, leading to a cumulative DY of 43%. Diagnostic rates were highest in CC (75%), bilateral cases (46%), complex ocular phenotypes (78%), patients with extraocular manifestations (55%) and positive family history (70%). Rare and possible new genotype–phenotype correlations and candidate genes (FAT1, POGZ) could be identified. In total, eight (likely) pathogenic variants in six genes (CYP1B1, ADAMTS18, MAB21L2, NHS, MFRP, CRYBB1) were not yet reported. A stepwise genetic testing approach starting with a broad multigene panel followed by exome sequencing provides higher diagnostic yield than limited phenotype-specific testing. Comprehensive genetic diagnosis is essential for prognosis, treatment and genetic counseling, underscoring the need for routine genetic testing and interdisciplinary collaboration in managing congenital eye malformations.
- 10 October 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (20) , 9854
Open AccessNext-Generation Sequencing in Congenital Eye Malformations: Identification of Genetic Causes and Comparison of Different Panel-Based Diagnostic Strategies
Congenital eye malformations like microphthalmia–anophthalmia–coloboma (MAC), anterior segment dysgenesis (ASD), primary congenital glaucoma (PCG) and congenital cataracts (CC) are significant causes of childhood visual impairment. Phenotypic heterogeneity often complicates diagnosis. The goal of this study was to optimize the diagnostic strategy for next-generation sequencing (NGS)-based procedures, thereby aiming to identify genetic causes of congenital eye malformations. Forty patients with congenital eye malformations were included. A primary diagnostic testing (PD) of a limited number of genes was followed by multigene panel (MGP) testing, including 186 eye-related genes, and exome sequencing. Causative variants were identified in 17 patients (43%) and clinically relevant variants of uncertain significance (VUS) in 6 patients (15%). PD had a diagnostic yield (DY) of 15%, MGP of 29% and exome sequencing of 4%, leading to a cumulative DY of 43%. Diagnostic rates were highest in CC (75%), bilateral cases (46%), complex ocular phenotypes (78%), patients with extraocular manifestations (55%) and positive family history (70%). Rare and possible new genotype–phenotype correlations and candidate genes (FAT1, POGZ) could be identified. In total, eight (likely) pathogenic variants in six genes (CYP1B1, ADAMTS18, MAB21L2, NHS, MFRP, CRYBB1) were not yet reported. A stepwise genetic testing approach starting with a broad multigene panel followed by exome sequencing provides higher diagnostic yield than limited phenotype-specific testing. Comprehensive genetic diagnosis is essential for prognosis, treatment and genetic counseling, underscoring the need for routine genetic testing and interdisciplinary collaboration in managing congenital eye malformations.
- 22 July 2025
- Published by Wolters Kluwer Health in Cornea
Muraine Sutures for Hydrops in Patients After Penetrating Keratoplasty
Purpose: To report the clinical characteristics of 7 cases of corneal hydrops after penetrating keratoplasty (PKP) for keratoconus and the postoperative results for 6 of these patients treated with predescemetal sutures (also known as Muraine sutures). Methods: We conducted a retrospective cohort study of all patients who presented at our center with secondary hydrops after PKP for keratoconus from 2023 to 2025. Results: Seven patients (6 male) presented with corneal hydrops on average 26.8 years (range 20–32 years) after initial PKP. The time between symptom onset and surgery ranged from 1 day to 1 year (mean 12.3 weeks). In all cases, a tear in Descemet membrane could be identified at the temporal or inferotemporal graft–host interface using anterior segment OCT and/or slit-lamp examination. We performed Muraine sutures in 6 patients, all of whom showed significant clearing and reduction of corneal swelling within a few days. Best-corrected visual acuity improved from a mean preoperative value of logMAR 2.17 to logMAR 0.62 at the final follow-up (mean: 10.8 months; range: 6–17 months). Conclusions: This is the first description of the use and surgical results of Muraine sutures for the treatment of corneal hydrops after PKP. Owing to its rarity and potential confounding with graft failure and late rejection, this condition may be underdiagnosed. In all cases, corneal edema resolved rapidly, resulting in a sustained significant improvement in visual acuity. Therefore, repeat keratoplasty could be avoided in all cases until now.
- 22 July 2025
- Published by Wolters Kluwer Health in Cornea
Muraine Sutures for Hydrops in Patients After Penetrating Keratoplasty
Purpose: To report the clinical characteristics of 7 cases of corneal hydrops after penetrating keratoplasty (PKP) for keratoconus and the postoperative results for 6 of these patients treated with predescemetal sutures (also known as Muraine sutures). Methods: We conducted a retrospective cohort study of all patients who presented at our center with secondary hydrops after PKP for keratoconus from 2023 to 2025. Results: Seven patients (6 male) presented with corneal hydrops on average 26.8 years (range 20–32 years) after initial PKP. The time between symptom onset and surgery ranged from 1 day to 1 year (mean 12.3 weeks). In all cases, a tear in Descemet membrane could be identified at the temporal or inferotemporal graft–host interface using anterior segment OCT and/or slit-lamp examination. We performed Muraine sutures in 6 patients, all of whom showed significant clearing and reduction of corneal swelling within a few days. Best-corrected visual acuity improved from a mean preoperative value of logMAR 2.17 to logMAR 0.62 at the final follow-up (mean: 10.8 months; range: 6–17 months). Conclusions: This is the first description of the use and surgical results of Muraine sutures for the treatment of corneal hydrops after PKP. Owing to its rarity and potential confounding with graft failure and late rejection, this condition may be underdiagnosed. In all cases, corneal edema resolved rapidly, resulting in a sustained significant improvement in visual acuity. Therefore, repeat keratoplasty could be avoided in all cases until now.
- Open Access
- 9 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (8) , 2585
Keratometry Changes Between Year Seven and Twelve After Corneal Crosslinking in Patients with Keratoconus
Background/Objectives: To evaluate the timing and extent to which late keratometric changes can occur between year 7 and 12 after corneal collagen crosslinking (CXL) in patients with keratoconus. Methods: A subgroup of a retrospective cohort study of all consecutive patients who underwent CXL at our cornea center between 2007 and 2011 was analyzed. The inclusion criteria consisted of CXL according to the Dresden protocol and a full set of keratometry parameters collected by Scheimpflug tomography preoperatively and at year 7, 9 and 12 after CXL. Results: A total of 46 eyes of 35 patients were included. The most relevant keratometric parameters (Kmax, TCT, K1, K2 and anterior astigmatism) decreased statistically significantly at year 7 after CXL, while there was no relevant difference for posterior astigmatism and the flat axes of anterior and posterior astigmatism. All keratometric parameters (except for K2) remained stable between year 7 and 12 without statistically significant change, according to mixed effect model regression analysis. BCVA improved statistically significant between the baseline and year 7 and remained stable until year 12. Suspected disease progression was noted in two patients (4.3%) between year 7, 9 and 12 post-CXL. Conclusions: Keratometric and functional results improve significantly 7 years after CXL in comparison to preoperative values and show very effective stabilization without clinically relevant changes up to year 12. However, while the risk of disease progression decreases remarkably after 7 years, in rare cases, suspected progression can occur even up to year 12. Therefore, regular control visits with keratometry measurements are advisable at least every 2 to 3 years in the late postoperative course.
- 9 April 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (8) , 2585
Open AccessKeratometry Changes Between Year Seven and Twelve After Corneal Crosslinking in Patients with Keratoconus
Background/Objectives: To evaluate the timing and extent to which late keratometric changes can occur between year 7 and 12 after corneal collagen crosslinking (CXL) in patients with keratoconus. Methods: A subgroup of a retrospective cohort study of all consecutive patients who underwent CXL at our cornea center between 2007 and 2011 was analyzed. The inclusion criteria consisted of CXL according to the Dresden protocol and a full set of keratometry parameters collected by Scheimpflug tomography preoperatively and at year 7, 9 and 12 after CXL. Results: A total of 46 eyes of 35 patients were included. The most relevant keratometric parameters (Kmax, TCT, K1, K2 and anterior astigmatism) decreased statistically significantly at year 7 after CXL, while there was no relevant difference for posterior astigmatism and the flat axes of anterior and posterior astigmatism. All keratometric parameters (except for K2) remained stable between year 7 and 12 without statistically significant change, according to mixed effect model regression analysis. BCVA improved statistically significant between the baseline and year 7 and remained stable until year 12. Suspected disease progression was noted in two patients (4.3%) between year 7, 9 and 12 post-CXL. Conclusions: Keratometric and functional results improve significantly 7 years after CXL in comparison to preoperative values and show very effective stabilization without clinically relevant changes up to year 12. However, while the risk of disease progression decreases remarkably after 7 years, in rare cases, suspected progression can occur even up to year 12. Therefore, regular control visits with keratometry measurements are advisable at least every 2 to 3 years in the late postoperative course.
- 30 January 2024
- Published by Wolters Kluwer Health in Cornea
- Vol. 43 (11) , 1397-1402
Keratometry Changes Between Year One to Seven After Corneal Cross-Linking in Patients With Keratoconus
Purpose: We evaluated the timing at and extent to which midterm to long-term keratometric changes can occur in year 1 to 7 after corneal collagen cross-linking (CXL) in patients with keratoconus. Methods: We conducted a subgroup analysis of a retrospective cohort study of all consecutive patients who underwent CXL at our cornea center between 2007 and 2011. The inclusion criteria comprised CXL according to the Dresden protocol and a full set of keratometry parameters collected by Scheimpflug tomography preoperatively and at year 1, 3, 5, and 7 after CXL. In addition, best-corrected visual acuity was evaluated. Results: Sixty-three eyes of 47 patients were enrolled. Mean age was 25.46 years ±7.39 years (80.9% male patients). All relevant keratometric parameters showed significant improvement at year 1 after CXL (except for posterior astigmatism). According to mixed-effects model analysis, they all showed further significant change at different points in time between year 1, 3, 5, and 7 (except for K1). In addition, best-corrected visual acuity improved statistically significant between year 1, 3, 5, and 7. Suspected disease progression was noted in 22.2% of patients, mostly between year 1 and 3 after CXL. Conclusions: After initial improvement 1 year after CXL, keratometric and functional parameters were stable until year 5 after CXL in most cases; further improvement can take place even after up to 7 years post-CXL. By contrast, in case of disease progression, changes seem to occur already between year 1 and 3 after CXL.
- 30 January 2024
- Published by Wolters Kluwer Health in Cornea
- Vol. 43 (11) , 1397-1402
Keratometry Changes Between Year One to Seven After Corneal Cross-Linking in Patients With Keratoconus
Purpose: We evaluated the timing at and extent to which midterm to long-term keratometric changes can occur in year 1 to 7 after corneal collagen cross-linking (CXL) in patients with keratoconus. Methods: We conducted a subgroup analysis of a retrospective cohort study of all consecutive patients who underwent CXL at our cornea center between 2007 and 2011. The inclusion criteria comprised CXL according to the Dresden protocol and a full set of keratometry parameters collected by Scheimpflug tomography preoperatively and at year 1, 3, 5, and 7 after CXL. In addition, best-corrected visual acuity was evaluated. Results: Sixty-three eyes of 47 patients were enrolled. Mean age was 25.46 years ±7.39 years (80.9% male patients). All relevant keratometric parameters showed significant improvement at year 1 after CXL (except for posterior astigmatism). According to mixed-effects model analysis, they all showed further significant change at different points in time between year 1, 3, 5, and 7 (except for K1). In addition, best-corrected visual acuity improved statistically significant between year 1, 3, 5, and 7. Suspected disease progression was noted in 22.2% of patients, mostly between year 1 and 3 after CXL. Conclusions: After initial improvement 1 year after CXL, keratometric and functional parameters were stable until year 5 after CXL in most cases; further improvement can take place even after up to 7 years post-CXL. By contrast, in case of disease progression, changes seem to occur already between year 1 and 3 after CXL.